Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.

Lipoprotein(a) [Lp(a)] concentration and apolipoprotein(a) [apo(a)] isoforms (identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE] and Western blotting) were determined in a group of 508 asymptomatic Caucasian members of the community and in 318 Caucasian patients with...

Detaylı Bibliyografya
Asıl Yazarlar:	Farrer, M, Game, F, Albers, C, Neil, H, Winocour, P, Laker, M, Adams, P, Alberti, K
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	1994

Benzer Materyaller

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
Yazar:: Farrer, M, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery.
Yazar:: Skinner, J, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery.
Yazar:: Skinner, J, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
Yazar:: Farrer, M, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women.
Yazar:: Winocour, P, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year.
Yazar:: Farrer, M, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Patient-related outcomes five years after coronary artery bypass graft surgery.
Yazar:: Skinner, J, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Yazar:: Ruotolo, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Assessing the impact of blood sample type on the estimated prevalence of impaired glucose tolerance and diabetes mellitus in epidemiological surveys.
Yazar:: Farrer, M, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
Yazar:: Parish, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

REMNANT LIPOPROTEINS AND CORONARY ARTERY DISEASE PROGRESSION
Yazar:: Karpe, F, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Coronary artery superoxide production and nox isoform expression in human coronary artery disease.
Yazar:: Guzik, T, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Clinical outcome measures eight years following Coronary Artery Bypass Grafting (CABG): A prospective cohort study
Yazar:: Mackin, P, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
Yazar:: Karjalainen, MK, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Effects of simvastatin on plasma lipoproteins and response to arterial injury in wild-type and apolipoprotein-E-deficient mice.
Yazar:: Choudhury, R, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
Yazar:: Tornvall, P, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Study On Apolipoprotein E (Apoe) Gene Polymorphism And Coronary Artery Disease Biomarker In Diabetic Patients
Yazar:: Abdul Sani, Athirah
Baskı/Yayın Bilgisi: (2016)

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
Yazar:: Erqou, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion
Yazar:: Stein, E, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Independent relevance of renal function for coronary artery disease
Yazar:: Hopewell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Urinary apolipoprotein A1 and its potential as a biomarker for coronary artery disease in young adults
Yazar:: Norbaiyah, Mohamed Bakrim, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein.
Yazar:: Demant, T, ve diğerleri
Baskı/Yayın Bilgisi: (1988)

High-density lipoprotein characteristics and coronary artery disease: a Mendelian randomization study
Yazar:: Prats-Uribe, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD
Yazar:: Lamprea-Montealegre, J, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Postprandial lipoproteins and progression of coronary atherosclerosis.
Yazar:: Karpe, F, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

HYPERTRIGLYCERIDEMIA, TRIGLYCERIDE-RICH LIPOPROTEINS, AND CORONARY ATHEROSCLEROSIS
Yazar:: Hamsten, A, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
Yazar:: Tornvall, P, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease
Yazar:: Mani, D. R., ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses
Yazar:: Ibi, D, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Soluble inflammatory biomarkers and apolipoprotein A1 gene variants in low high density lipoprotein concentration / Nurul Atiqah Mohd Mokhsin
Yazar:: Mohd Mokhsin, Nurul Atiqah
Baskı/Yayın Bilgisi: (2016)

Association of apolipoprotein E genotypes with lipid levels and coronary risk.
Yazar:: Bennet, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients.
Yazar:: Eberini, I, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease.
Yazar:: Kaudewitz, D, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Loss of PDZK1 Causes Coronary Artery Occlusion and Myocardial Infarction in Paigen Diet-Fed Apolipoprotein E Deficient Mice
Yazar:: Krieger, Monty, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Loss of PDZK1 Causes Coronary Artery Occlusion and Myocardial Infarction in Paigen Diet-Fed Apolipoprotein E Deficient Mice
Yazar:: Yesilaltay, Ayce, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study.
Yazar:: Peacock, R, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides.
Yazar:: Karpe, F, ve diğerleri
Baskı/Yayın Bilgisi: (2001)